These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14601011)

  • 61. Adjusting survival analysis for the presence of unadjudicated study events.
    Cook TD
    Control Clin Trials; 2000 Jun; 21(3):208-22. PubMed ID: 10822119
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design and monitoring of survival trials in complex scenarios.
    Luo X; Mao X; Chen X; Qiu J; Bai S; Quan H
    Stat Med; 2019 Jan; 38(2):192-209. PubMed ID: 30281165
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A testing procedure for survival data with few responders.
    Freidlin B; Korn EL
    Stat Med; 2002 Jan; 21(1):65-78. PubMed ID: 11782051
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An illustrative statistical analysis of cutoff-based randomized clinical trials.
    Cappelleri JC; Trochim WM
    J Clin Epidemiol; 1994 Mar; 47(3):261-70. PubMed ID: 8138836
    [TBL] [Abstract][Full Text] [Related]  

  • 65. INTERMED: a tool for controlling for confounding variables and designing multimodal treatment.
    Huyse FJ; de Jonge P; Lyons JS; Stiefel FC; Slaets JP
    J Psychosom Res; 1999 Apr; 46(4):401-2. PubMed ID: 10340241
    [No Abstract]   [Full Text] [Related]  

  • 66. Debate on measures of outcome.
    Tugwell P; Knottnerus JA; Wells G; Idzerda L
    J Clin Epidemiol; 2010 Jan; 63(1):1. PubMed ID: 19958999
    [No Abstract]   [Full Text] [Related]  

  • 67. Survival analysis of randomized clinical trials adjusted for patients who switch treatments.
    White IR
    Stat Med; 1997 Nov; 16(22):2619-21. PubMed ID: 9403960
    [No Abstract]   [Full Text] [Related]  

  • 68. Misadjustment of post-trial life-prolonging therapies in the second interim analysis of the MAGNITUDE trial.
    Chen P; Liu M; Li GY; Sun F; Li T
    Ann Oncol; 2024 Jan; 35(1):140-141. PubMed ID: 37871700
    [No Abstract]   [Full Text] [Related]  

  • 69. ISCHEMIA: Establishing the Primary End Point.
    Bangalore S; Maron DJ; Reynolds HR; Stone GW; O'Brien SM; Alexander KP; Hochman JS
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004791. PubMed ID: 29752391
    [No Abstract]   [Full Text] [Related]  

  • 70. Randomized trials for the real world: making as few and as reasonable assumptions as possible.
    Baker SG; Kramer BS
    Stat Methods Med Res; 2008 Jun; 17(3):243-52. PubMed ID: 17925312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methods for mid-course corrections in clinical trials with survival outcomes.
    Cook TD
    Stat Med; 2003 Nov; 22(22):3431-47. PubMed ID: 14601011
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical trial optimization: Monte Carlo simulation Markov model for planning clinical trials recruitment.
    Abbas I; Rovira J; Casanovas J
    Contemp Clin Trials; 2007 May; 28(3):220-31. PubMed ID: 16979387
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous group sequential analysis of rank-based and weighted Kaplan-Meier tests for paired censored survival data.
    Andrei AC; Murray S
    Biometrics; 2005 Sep; 61(3):715-20. PubMed ID: 16135022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bayesian model selection: analysis of a survival model with a surviving fraction.
    Seltman H; Greenhouse J; Wasserman L
    Stat Med; 2001 Jun; 20(11):1681-91. PubMed ID: 11391695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Randomized trials and registries: a computer simulation to study the impact of surgeon/patient factors on outcomes.
    Weiner BK; Patel R; Noble P
    Spine J; 2008; 8(6):959-67. PubMed ID: 18243058
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.